Treatment of patients with neonatal-onset multisystem inflammatory disease/chronic infantile neurologic, cutaneous, articular syndrome: comment on the article by Matsubara et al

Arthritis Rheum. 2007 Jun;56(6):2099-101; author reply 2101-2. doi: 10.1002/art.22561.
No abstract available

Publication types

  • Case Reports
  • Comment
  • Letter
  • Research Support, N.I.H., Intramural

MeSH terms

  • Antirheumatic Agents / therapeutic use
  • Autoimmune Diseases / drug therapy
  • Central Nervous System Diseases / drug therapy
  • Etanercept
  • Fever / drug therapy*
  • Fever / metabolism
  • Humans
  • Immunoglobulin G / therapeutic use
  • Infant
  • Inflammation / drug therapy*
  • Inflammation / metabolism
  • Interleukin 1 Receptor Antagonist Protein / therapeutic use
  • Interleukin-1beta / metabolism
  • Interleukin-6 / metabolism
  • Joint Diseases / drug therapy
  • Meningitis, Aseptic / drug therapy*
  • Meningitis, Aseptic / metabolism
  • Papilledema / drug therapy*
  • Papilledema / metabolism
  • Receptors, Tumor Necrosis Factor / therapeutic use
  • Syndrome

Substances

  • Antirheumatic Agents
  • Immunoglobulin G
  • Interleukin 1 Receptor Antagonist Protein
  • Interleukin-1beta
  • Interleukin-6
  • Receptors, Tumor Necrosis Factor
  • Etanercept